VALUE MEASUREMENT IN CEA: FAIRNESS TO ELDERLY/DISABLED
CEA 的价值衡量:对老年人/残疾人的公平
基本信息
- 批准号:6387730
- 负责人:
- 金额:$ 32.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-05-01 至 2004-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (adapted from the Abstract): Cost-effectiveness analysis (CEA) has
been criticized for discriminating against people with disabilities, for
harming the elderly, for ignoring issues of fairness, and for undervaluing the
benefit of treating severely ill patients. Because the elderly often have
chronic disabilities that limit the amount they can improve their quality of
life with health programs, measures of the cost-effectiveness of programs
targeted toward the elderly appear relatively unfavorable. We think that
these problems can be overcome by distinguishing between the health related
utility brought by health care programs and the societal value of those
programs. The goal is to improve value measurement in CEA to make it fair to
the elderly and people with disabilities. To achieve this goal, we plan to
test and refine the person trade-off method (PTO) - a measure of the societal
value of health care programs. In a typical PTO elicitation, a subject is
asked how many people need to be cured of a health condition (e.g., severe
osteoarthritis) to equal the benefit of saving ten people's lives. Several
methodologic issues have arisen about the feasibility of PTO measurement. In
a series of six studies, we will explore these methodologic issues as well as
the cognitive processes people undergo when responding to PTO elicitations.
The team proposes to conduct PTO eliciatations from the general public using
face to face interviews. The primary source of subjects will be prospective
jurors at the Philadelphia County and Montgomery County Courthouses and mall
patrons from the Delaware Valley area. Studies 1 and 2 will explore way to
improve the consistency of PTO responses. Study 3 will explore the societal
value people place on preventive versus curative treatment programs. Study 4
will evaluate whether CEA undervalues treatment programs directed at saving
the lives of people with chronic disabilities. Study 5 will test whether the
importance people place on equity in responding to PTO elicitations is unduly
influenced by cognitive biases resulting from framing effects. Study 6 will
explore whether the value people place on treatment programs depends on
patients' ages, and whether the importance they place on age varies across
treatment programs (e.g., life saving programs versus programs that improve
function or reduce pain). The goal is to evaluate whether PTO determinations
can be an effective solution to the problems that arise when conventional
utility assessment is applied to the evaluation of health care programs for
the elderly and disabled.
描述(改编自摘要):成本效益分析 (CEA) 已
因歧视残疾人而受到批评
伤害老年人、忽视公平问题、低估老年人的价值
对治疗重症患者有好处。 因为老年人常常有
慢性残疾限制了他们提高生活质量的能力
生活与健康计划、计划成本效益的衡量
针对老年人则显得相对不利。 我们认为
这些问题可以通过区分健康相关的问题来解决
医疗保健计划带来的效用及其社会价值
程序。 目标是改进 CEA 的价值衡量,使其公平
老年人和残疾人。 为了实现这一目标,我们计划
测试并完善人员权衡方法(PTO)——一种社会衡量标准
医疗保健计划的价值。 在典型的 PTO 启发中,主题是
询问有多少人的健康状况需要治愈(例如,严重的
骨关节炎)相当于拯救十个人的生命。 一些
关于 PTO 测量的可行性出现了方法学问题。 在
一系列六项研究,我们将探讨这些方法论问题以及
人们在响应 PTO 诱导时所经历的认知过程。
该团队建议使用 PTO 向公众进行启发
面对面采访。 主题的主要来源将是前瞻性的
费城县和蒙哥马利县法院和购物中心的陪审员
来自特拉华谷地区的顾客。 研究 1 和 2 将探索方法
提高 PTO 响应的一致性。 研究 3 将探讨社会
人们对预防性治疗方案与治疗性治疗方案的重视程度。 研究4
将评估 CEA 是否低估了旨在挽救生命的治疗计划
慢性残疾人的生活。 研究 5 将测试是否
人们在回应 PTO 启发时过分重视公平性
受框架效应产生的认知偏差的影响。 研究 6 将
探讨人们对治疗方案的重视是否取决于
患者的年龄,以及他们对年龄的重视程度是否因人而异
治疗计划(例如,挽救生命的计划与改善生命的计划)
发挥作用或减轻疼痛)。 目标是评估 PTO 决定是否
可以有效解决传统方法使用时出现的问题
效用评估应用于医疗保健计划的评估
老年人和残疾人。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PETER A UBEL其他文献
PETER A UBEL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PETER A UBEL', 18)}}的其他基金
Broadening Research Horizons - A Conference Proposal
拓宽研究视野——会议提案
- 批准号:
6753121 - 财政年份:2003
- 资助金额:
$ 32.17万 - 项目类别:
Identifying and reducing cognitive biases created by decision aids
识别并减少决策辅助造成的认知偏差
- 批准号:
7681174 - 财政年份:2002
- 资助金额:
$ 32.17万 - 项目类别:
Identifying and reducing cognitive biases created by decision aids
识别并减少决策辅助造成的认知偏差
- 批准号:
8145612 - 财政年份:2002
- 资助金额:
$ 32.17万 - 项目类别:
Identifying and reducing cognitive biases created by decision aids
识别并减少决策辅助造成的认知偏差
- 批准号:
7503430 - 财政年份:2002
- 资助金额:
$ 32.17万 - 项目类别:
Identifying and reducing cognitive biases created by decision aids
识别并减少决策辅助造成的认知偏差
- 批准号:
7886771 - 财政年份:2002
- 资助金额:
$ 32.17万 - 项目类别:
相似海外基金
Fixing the NDIS: cost, effectiveness and access for psychosocial disability
修复 NDIS:心理社会残疾的成本、有效性和获取机会
- 批准号:
IL230100154 - 财政年份:2023
- 资助金额:
$ 32.17万 - 项目类别:
Industry Laureate Fellowships
Evaluating equitable access to diabetic retinopathy screening using social value judgement informed distributional cost-effectiveness analyses (Oppression framework informed equity cost-effectiveness analysis of diabetic retinopathy screening)
使用社会价值判断知情的分配成本效益分析评估糖尿病视网膜病变筛查的公平性(压迫框架知情的糖尿病视网膜病变筛查公平成本效益分析)
- 批准号:
495212 - 财政年份:2023
- 资助金额:
$ 32.17万 - 项目类别:
Measuring the Impact of the Value Flower and Unobserved Heterogeneity on the Cost Effectiveness and Use of Novel Treatments for Alzheimer's Disease and Related Dementias
衡量价值花和未观察到的异质性对阿尔茨海默病和相关痴呆症新疗法的成本效益和使用的影响
- 批准号:
10658457 - 财政年份:2023
- 资助金额:
$ 32.17万 - 项目类别:
Assessing the Clinical and Cost-Effectiveness of a Virtual PEth-based Contingency Management for Adults with AUD
评估针对成人 AUD 的基于虚拟 PEth 的应急管理的临床和成本效益
- 批准号:
10717985 - 财政年份:2023
- 资助金额:
$ 32.17万 - 项目类别:
Modelling the Future of Home Health for Seniors - A Markov based Cost Effectiveness Analysis
模拟老年人家庭健康的未来 - 基于马尔可夫的成本效益分析
- 批准号:
484653 - 财政年份:2023
- 资助金额:
$ 32.17万 - 项目类别:
Fellowship Programs
Diagnosing and preventing HIV infection in adolescents and young adults in the US: clinical impact and cost-effectiveness
诊断和预防美国青少年和年轻人的艾滋病毒感染:临床影响和成本效益
- 批准号:
10772663 - 财政年份:2023
- 资助金额:
$ 32.17万 - 项目类别:
The effectiveness, cost-effectiveness, and budget impact of interventions to improve the delivery of cervical cancer screening in Puerto Rico.
波多黎各改善宫颈癌筛查的干预措施的有效性、成本效益和预算影响。
- 批准号:
10718886 - 财政年份:2023
- 资助金额:
$ 32.17万 - 项目类别:
Analysis of the cost-effectiveness of specific health checkups and health guidance, and examination of effective system.
分析特定健康检查和健康指导的成本效益,检查有效的制度。
- 批准号:
23K10290 - 财政年份:2023
- 资助金额:
$ 32.17万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Cost-effectiveness study of Retrieval Service
检索服务的成本效益研究
- 批准号:
23K08482 - 财政年份:2023
- 资助金额:
$ 32.17万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Efficacy and cost-effectiveness of Internet cognitive behavioral therapy for irritable bowel syndrome
互联网认知行为疗法治疗肠易激综合征的疗效和成本效益
- 批准号:
23K12915 - 财政年份:2023
- 资助金额:
$ 32.17万 - 项目类别:
Grant-in-Aid for Early-Career Scientists